Av. Marathon 1000 - Ñuñoa
Santiago, Chile
Ingrid Heitmann Ghigliotto - Director
www.ispch.cl
Chile's Institute of Hygiene was developed in 1892. Initial activities involved developing a network of chemistry and bacteriology laboratories. Later, it began to produce serums and vaccines, including anti-rabies vaccine and other animal vaccines. Subsequently, the Institute expanded to play a role as a National Reference Laboratory to help control infectious diseases such as diphtheria, scarlet fever, typhoid fever, and anthrax. Special attention was paid to standardizing methods of diagnosis, exercising quality control of both domestic and imported pharmaceutical products, and producing much-needed vaccines.
The Public Health Institute of Chile (ISP), as it is known today, was created in 1979. In the years since, ISP has established various centers and departments to help promote positive health in Chile. A special emphasis is currently on prevention and control of communicable diseases. ISP remains an active partner with WHO and PAHO for surveillance of infectious diseases and detection of the emergence of new diseases. Outbreaks of hantavirus, dengue, and bioterrorism, among others, yielded immediate responses from ISP, which has acquired equipment, designed techniques, and trained technical professionals to deal successfully with each of these types of emergencies.
POPULATION:
16,601,707
SIZE:
756,102 sq km
GDP (USD):
$245.1 billion
AVERAGE INCOME:
$14,900
LEADING CAUSES OF DEATH:
- Heart disease
- Cancer
- Digestive diseases
- Respiratory diseases
- Respiratory infections
INFANT MORTALITY:
7.71 deaths/1,000 live births
AVERAGE LIFE SPAN:
Male: 75
Female: 81
Source: WHO